MobiHealthNews

FDA approves Dexcom for Bluetooth-enabled CGM G5

The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...
Medscape

Implantable Glucose Sensor Bests Competitors in Head-to-Head

ORLANDO — In a head-to-head trial comparing three currently available continuous glucose monitors (CGMs) for real-world use in diabetes, the newly approved implantable glucose monitor Eversense ...
Medscape

FDA Okays Use of Dexcom G5 CGM for Insulin Dosing

For the first time, the US Food and Drug Administration has approved the use of a continuous glucose monitoring (CGM) system to replace finger-stick testing for determining insulin doses. The decision ...
Business Wire

Tandem Diabetes Care Announces FDA Approval and Launch of t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration

Dexcom is also consistently rated the #1 CGM brand in independent patient surveys 5. In addition to integration with the t:slim X2 Pump, dynamic glucose data from the Dexcom G5 Mobile CGM can be ...
Healio

Next-generation CGM with 15-day sensor improves upon previous generation’s accuracy

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Business Wire

NIH-funded International Diabetes Closed Loop (IDCL) Trial to Combine Technologies from Tandem Diabetes Care, Dexcom and TypeZero

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.
MobiHealthNews

Dexcom's integrated CGM receives FDA nod

Yesterday Dexcom got the nod from the FDA to market their Dexcom G6, an integrated continuous glucose monitoring system (iCGM), making it the first interoperable CGM to get the designation. “We are a ...
Morningstar

Dexcom Buoyed by Penetration of Type 2 Market; Raising Our Fair Value Estimate

Dexcom enjoys a well-established track record for introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, Dexcom has captured an impressive ...
CNET

The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM Wearable

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users. Taylor Leamey wrote about all things wellness for CNET, specializing in ...
Nasdaq

DexCom (DXCM) Launches Latest CGM Sensor ONE in France

DexCom, Inc. DXCM announced that its DexCom ONE continuous glucose monitoring (CGM) system has been launched in France for people with diabetes. The latest CGM sensor from the company’s portfolio has ...
FierceBiotech

Dexcom's next-gen G7 diabetes sensor scores European approval

Dexcom has obtained European approval for the latest generation of its wearable diabetes sensor, the G7 continuous glucose monitor, for adults and children ages two and up. Designed to be 60% smaller ...